retatrutide clinical trial dose retatrutide Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP Retatrutide Dosing Schedule: Proven 2026

Berberine may affect blood glucose levels and interact with prescribed treatments, requiring closer monitoring and coordinated care

However, other causes of hair loss should be ruled out by a healthcare professional, particularly if the pattern seems unusual or severe

Chinese consumers prioritise safety when they choose weight loss products, meaning the potential side effects of taking GLP-1 drugs, such as nausea, rebound effect and semaglutide face may prevent people from taking this medicine for weight loss purposes, says Forsyth

Self-administration of unlicensed peptides without medical supervision carries significant safety risks

HEALTH & WELLNESS No More Food Noise: resbiotics resM GLP-1 Postbiotic Review Ever feel like food is constantly on your mind

Nauck M, Frid A, Hermansen K, Shah NS, Tankova T, Mitha IH, et al